DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 42 filers reported holding DECIBEL THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $38,935 | +27.5% | 10,113 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $30,541 | +47.3% | 10,113 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $20,732 | -40.8% | 10,113 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $35,000 | -18.6% | 10,113 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $43,000 | +38.7% | 10,113 | 0.0% | 0.01% | +66.7% |
| Q1 2022 | $31,000 | -34.0% | 10,113 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $47,000 | – | 10,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,139,685 | $14,600,000 | 3.65% |
| Samsara BioCapital, LLC | 826,422 | $3,843,000 | 0.75% |
| Orbimed Advisors | 4,945,192 | $22,995,000 | 0.30% |
| Alphabet Inc. | 1,636,258 | $7,609,000 | 0.18% |
| Casdin Capital, LLC | 1,170,048 | $5,441,000 | 0.15% |
| HARVARD MANAGEMENT CO INC | 328,798 | $1,529,000 | 0.14% |
| Bronte Capital Management Pty Ltd. | 157,216 | $731,000 | 0.05% |
| ATLAS CAPITAL ADVISORS LLC | 41,025 | $190,766,000 | 0.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 263,600 | $1,226,000 | 0.02% |
| Woodline Partners LP | 275,001 | $1,279,000 | 0.02% |